These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753. Wong PC; Price WA; Chiu AT; Carini DJ; Duncia JV; Johnson AL; Wexler RR; Timmermans PB Hypertension; 1990 Jun; 15(6 Pt 2):823-34. PubMed ID: 2351436 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody. Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502 [TBL] [Abstract][Full Text] [Related]
5. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist. Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348 [TBL] [Abstract][Full Text] [Related]
7. Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307). Wong PC; Chiu AT; Price WA; Thoolen MJ; Carini DJ; Johnson AL; Taber RI; Timmermans PB J Pharmacol Exp Ther; 1988 Oct; 247(1):1-7. PubMed ID: 3171969 [TBL] [Abstract][Full Text] [Related]
8. Nonpeptide angiotensin II receptor antagonists: a novel class of antihypertensive agents. Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL Blood Vessels; 1990; 27(2-5):295-300. PubMed ID: 1978694 [TBL] [Abstract][Full Text] [Related]
9. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonists. From discovery to antihypertensive drugs. Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL Hypertension; 1991 Nov; 18(5 Suppl):III136-42. PubMed ID: 1937677 [TBL] [Abstract][Full Text] [Related]
11. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531 [TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacology of DuP 753. Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454 [TBL] [Abstract][Full Text] [Related]
13. EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist. Wong PC; Duncia JV; Chiu AT; Olson RE; Rominger DH; Tam SW; Timmermans PB J Pharmacol Exp Ther; 1993 Nov; 267(2):641-7. PubMed ID: 7902431 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885 [TBL] [Abstract][Full Text] [Related]
15. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB Hypertension; 1990 May; 15(5):459-68. PubMed ID: 2185150 [TBL] [Abstract][Full Text] [Related]
16. Nonpeptide angiotensin II receptor antagonists. Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL Am J Hypertens; 1990 Aug; 3(8 Pt 1):599-604. PubMed ID: 2222950 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist. Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist. Wong YN; Wong PC J Pharm Pharmacol; 1996 May; 48(5):492-7. PubMed ID: 8799873 [TBL] [Abstract][Full Text] [Related]
20. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig. Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]